|
PRESS RELEASES
Contacts: Anthony G. Viscogliosi, Viscogliosi Bros, LLC (212) 583-9700
ext. 101
Chris Storer, Creative Partners (203) 952-6403
SMALL BONE INNOVATIONS COMPLETES INTEGRATION OF ACQUIRED COMPANIES AND
LICENSED PRODUCTS
- Creates five business units focused on bone
and joint repair and trauma in extremities
NEW YORK – November 15, 2005 - Small
Bone Innovations, LLC (SBI) announced that it has completed the integration
of four companies and two licensed technologies, acquired during the
past year, by creating five business units to meet its goal of becoming
the global leader in small bone and joint reconstruction and trauma
in the upper and lower extremities.
The business units are: Arthroplasty; Internal Fixation; External Fixation;
Tissue Technology; and International Business.
Anthony G. Viscogliosi, Chairman & CEO of SBI, said: “Following
the acquisition, in May, of Fixano S.A.S., we began structuring the
company to accelerate product innovation and build a comprehensive range
of products, working closely with surgeons who share our quest to improve
dramatically the quality of patient care.”
He noted that SBI has added more than 100 staff and technicians, upgraded
its manufacturing processes and is building a global distribution network
in 28 countries that includes stocking international distributors, independent
commissioned sales agencies, and direct sales representation in France
and certain major underserved markets in the U.S.
Michael Simpson, COO of SBI added that this business model will ultimately
offer surgeons and patients “a single source for the broadest
and deepest set of market leading implants, instrumentation and educational
tools ever assembled for small bone and joint treatment.”
SBI is already offering 42 different product systems across a spectrum
of small bone and joint indications. Of a further 25 developmental products,
SBI has recently received FDA 510(k) market clearances for its ReFIX™
line of bioresorbable pins and screws, its SBI Universal Hand System™,
a modular internal fixation set, and a new distal radius plating system.
In addition to the products of the acquired companies, SBI has also
begun marketing the Artelon® CMC-I Spacer, for basal thumb osteoarthritis,
under a license from Artimplant AB of Sweden that recently was extended
to cover four more potential applications in the thumb, wrist and foot.
“There is extensive interest in the Artelon spacer technology
due to its tissue-sparing qualities and the fact that, in the case of
the CMC-I Spacer, it avoids removal of the trapezial bone, thereby restoring
function as well as relieving pain. This technology neatly encapsulates
everything that SBI stands for by helping patients lead a better quality
of life,” Viscogliosi said.
SBI was formally introduced at this year’s American Academy of
Orthopaedic Surgeons convention , and was the dominant exhibitor at
last month’s annual meeting of the American Society for Surgery
of the Hand in San Antonio, TX (Sept. 22-24).
SBI’s five business units and their principal product systems
are as follows:
Arthroplasty: PIP and MCP joint implants;
the Avanta Total Wrist; the uHead™ ulnar head implant; and rHead™
and rHead™ Recon radial head implants (SBI offers two radial head
options); and. The unit is managed by H. Doug Plunkett, Vice President,
Arthoplasty Systems.
Internal Fixation Systems: SBI Universal
Hand System™ stainless steel modular hand set; the Diamond™
Carpal Fusion Plate; SCS™ Distal Radius Plates (volar and dorsal),
and the Carpal Button. The unit is managed by Kevin E. Kiel, Vice President,
Internal Fixation Systems.
External Fixation Systems: Wide range
of VueFIX™ finger, hand, wrist, ankle and general external fixation
systems; RingFIX™ circular wire fixation systems for trauma/reconstructive
surgery in the foot and ankle. The unit is managed by Alan B. Miller,
Vice President, External Fixation Systems.
Tissue Technology Systems: Artelon®
CMC-I spacer; ReFIX™ bioresorbable screws and pins; Actipore®
porous metal biomaterial. The unit is managed by Shawn T. Huxel, Vice
President, Tissue Technology.
International Business: Sales, marketing
and distribution of a CE-marked product portfolio; and manufacturing;
based at Bourg-en-Bresse, France. The unit is managed by Jean-Jacques
Martin, Vice President, International Business.
About SBI
Small Bone Innovations, LLC (SBI) was founded in 2004 by Viscogliosi
Bros. LLC., (VB), the New York-based merchant banking firm that specializes
in the musculoskeletal /orthopedic sector. VB created SBI as the first
company to focus purely on small bone & joint science. By integrating
established companies and professionals in the field, SBI today offers
a broad, clinically proven portfolio of products and technologies to
treat trauma and diseases in small bones & joints.
VB’s acquisitions and technology licenses include: Avanta
Orthopaedics (hand/wrist/elbow arthroplasty and trauma products
– USA); Envision (implant manufacturing –
USA); Actipore™ (porous metal technology –
Canada); Artelon® (biologically active & biodegradable
technology – Sweden); Xtremi-T (resorbable trauma
technology – USA); Fixano, S.A.S. (orthopedics,
trauma and spine products - France).
For more information on SBI visit: www.totalsmallbone.com
About Viscogliosi Bros., LLC
Established by Marc R. Viscogliosi, John J. Viscogliosi and Anthony
G. Viscogliosi in New York City in 1999, VB was the first venture capital/private
equity and merchant banking firm dedicated to the musculoskeletal/orthopedics
sector of the health care industry. Today, VB is a leading independent
firm with a mission to create, build and finance companies founded on
innovations developed by surgeons and uniquely focused on "life
changing" musculoskeletal/orthopedic technologies. VB has worldwide
surgeon, industry and trade relationships and significant financial
expertise in the musculoskeletal/orthopedic sector.
As principals of VB, the Viscogliosi brothers have a combined total
of more than 35 years experience analyzing and investing in the musculoskeletal/orthopedics
sector. The have pioneered innovative financial, strategic and management
initiatives for companies in the sector, from start-up, seed and development
stage all the way to exit, while helping thousands of people lead better
lives through the orthopedic and spinal products marketed and sold by
the companies they have assisted in developing and financing.
> Back to Press Releases
|
|
